Aquí encontrará nuestros anuncios más recientes, que incluyen asociaciones, lanzamientos de productos y éxitos de pruebas. Lea a continuación para conocer nuestros anuncios más recientes.
ObvioHealth, in partnership with IQVIA Consumer Health, announces the launch of a fully decentralized clinical trial with Jovie USA to bring an innovative goat milk-based infant formula to the United States.
ObvioHealth, a pioneering virtual research organization, announces the launch of a proprietary application programming interface (API) tailored specifically for digital therapeutic (DTx) clinical trials.
ObvioHealth and Sterling IRB today announce a partnership to help speed access and adoption of decentralized clinical trials. The partnership makes Sterling IRB the preferred Institutional Review Board for ObvioHealth.
ObvioHealth announces it has been rated as the top “major contender” on Everest Group’s 2022 PEAK Matrix®, an industry report providing analysis and insights on decentralized clinical trial vendors. ObvioHealth is ranked 5th overall in a field of 24 industry players.
ObvioHealth, a global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical trials (DCT), is collaborating with Oracle in Asia Pacific to help get breakthrough therapies to market faster through more efficient integration of diverse data sets. The alliance will enable the rapid collection, integration and analysis of multi-source data collected from sites, patients, devices and labs.